- Home
- MHH vs SLRX Comparison
MHH vs SLRX Comparison
Compare MHH & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHH
- SLRX
- Stock Information
- Founded
- MHH 1986
- SLRX N/A
- Country
- MHH United States
- SLRX United States
- Employees
- MHH N/A
- SLRX N/A
- Industry
- MHH Professional Services
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- MHH Consumer Discretionary
- SLRX Health Care
- Exchange
- MHH Nasdaq
- SLRX Nasdaq
- Market Cap
- MHH 78.2M
- SLRX 1.8M
- IPO Year
- MHH N/A
- SLRX N/A
- Fundamental
- Price
- MHH $7.04
- SLRX $0.90
- Analyst Decision
- MHH
- SLRX
- Analyst Count
- MHH 0
- SLRX 0
- Target Price
- MHH N/A
- SLRX N/A
- AVG Volume (30 Days)
- MHH 14.3K
- SLRX 3.5M
- Earning Date
- MHH 08-06-2025
- SLRX 08-08-2025
- Dividend Yield
- MHH N/A
- SLRX N/A
- EPS Growth
- MHH N/A
- SLRX N/A
- EPS
- MHH 0.17
- SLRX N/A
- Revenue
- MHH $200,437,000.00
- SLRX N/A
- Revenue This Year
- MHH $1.22
- SLRX N/A
- Revenue Next Year
- MHH $5.41
- SLRX N/A
- P/E Ratio
- MHH $43.02
- SLRX N/A
- Revenue Growth
- MHH 3.93
- SLRX N/A
- 52 Week Low
- MHH $6.20
- SLRX $0.45
- 52 Week High
- MHH $16.00
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- MHH 50.16
- SLRX 50.55
- Support Level
- MHH $6.60
- SLRX $0.86
- Resistance Level
- MHH $6.85
- SLRX $1.33
- Average True Range (ATR)
- MHH 0.43
- SLRX 0.15
- MACD
- MHH 0.10
- SLRX -0.01
- Stochastic Oscillator
- MHH 46.77
- SLRX 40.19
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.